Concepedia

Publication | Open Access

A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis

DOIFull Paper Access

301

Citations

31

References

2018

Year

E. Michael Lewiecki, Tomasz Blicharski, Stefan Goemaere, Kurt Lippuner, Paul Meisner, Paul D. Miller, Akimitsu Miyauchi, Judy Maddox, Li Chen, S. Horlait
The Journal of Clinical Endocrinology & Metabolism

Abstract

Treatment with romosozumab for 12 months increased the spine and hip BMD compared with placebo and was well tolerated in men with osteoporosis.

References

YearCitations

Page 1